Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Glatiramer acetate Treatment Report
What is Glatiramer acetate?

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Slow my ALS progress 4 0
Other 3 0

Mouse over the table for more information

Dosages

  daily 20 mg daily 40 mg daily
  1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Glatiramer acetate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 50% Did not seem to work: 50%
Side effects too severe
1 50% Side effects too severe: 50%

See all 2 patients who’ve stopped taking Glatiramer acetate

Duration See details about how long patients take this treatment ▼

Currently Taking Glatiramer acetate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
2

Stopped Taking Glatiramer acetate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
0
1

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.